Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin trometamol versus ciprofloxacin for lower urinary tract infection in postmenopausal women
2006-006318-14Phase 3Terminated
- Sponsor
- Pharmazam
- Start
- Feb 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fosfomycin and ciprofloxacin in Lower Urinary Tract Infection (LUTI) (2 arms), sponsored by Pharmazam. Primary endpoint: Bacterial eradication after completion of antibiotic treatment. Started Feb 2007; status: terminated.
02
Drugs
fosfomycinciprofloxacin
03
Conditions
Lower Urinary Tract Infection (LUTI)
Beyond the preview
Go deeper on 2006-006318-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006318-14.